1. Medtech Insight

Jones And Luber Partner Up Again At Atlas Genetics

 
• By Tina Tan

Marc Jones is taking on the dual role of chief operating officer and chief financial officer at UK point-of-care diagnostics firm Atlas Genetics.

Atlas Genetics Ltd. has appointed Marc Jones chief operating officer and chief financial officer. Jones will be reunited with former colleague, Jeffrey Luber, Atlas' recently appointed CEO. Both Luber and Jones have worked together at Good Start Genetics Inc. , each holding the same roles that they do now at Atlas. Together, they raised successive rounds of capital at Good Start and helped to turn the company around before it was sold to Invitae Corp. .

Jones has also held senior corporate finance positions in various private companies such as T2 Biosystems Inc., Ivenix Inc., and others.

More from Leadership

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.